Tenaya Therapeutics, Inc. (TNYA) NASDAQ

2.15

+0.4(+22.86%)

Updated at October 17 04:00PM

Currency In USD

Valuation

Market Cap239.07M
Enterprise Value205.81M
P/E Ratio-1.53
PEG Ratio-0.23
Price/Sales Ratio9.6
Price/Book Ratio1.38
Enterprise/Revenue7.19
Enterprise/EBITDA-1.09

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterJune 30, 2024

Profitability

Profit Margin-6.84
Operating Margin-7.19

Management Effectiveness

Return On Assets-0.74
Return On Equity-0.81

Income Statement

Revenue0
Revenue/Share0.21
Gross Profit-8.69M
EBITDA-122.51M
Net Income-124.08M
Diluted EPS-1.68

Balance Sheet

Total Cash99.3M
Total Cash/Share1.16
Total Debt15.57M
Total Debt/Equity0.12
Current Ratio6.28
Book Value Per Share1.56

Price History

52-Week Change-3.15
52-Week High7.01
52-Week Low1.61
Moving Average 50 Days2.29
Moving Average 200 Days3.77

Statistics

Average Volume404,745
Shares Outstanding78.89M
% Held by Institutions70.23

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A